A new study published in Cancer Cell by researchers at the Broad Institute and the Dana-Farber Cancer Institute focuses on the cancer gene MCL1, according to a Broad press release. MCL1 inhibits apoptosis, and it is one of the most commonly mutated genes in several different kinds of cancer. The study highlights several compounds that repress MCL1.
A Deeper Look
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.